EBS vs TYL · rev $1.04B vs P/E 89, rev $1.26B
Emergent Biosolutions Inc (EBS) versus Tyler Technologies Inc (TYL) — a side-by-side from cached financials, not a winner call.
Emergent Biosolutions Inc (EBS) is a drug manufacturers - specialty & generic company listed on US.
Tyler Technologies Inc (TYL) is a software - application company listed on US.
Latest reported EBS revenue for 2024-12-31 was $1.04B. Net income was -$190.6M. Revenue was down 0.5% from 2023-12-31 to 2024-12-31. EBS currently screens at market cap $416.4M.
Latest reported TYL revenue for 2026-06-30 was $1.26B. Net income was $174.7M. TYL currently screens at market cap $25.57B and trailing P/E 89.3.
EBS currently screens at market cap $416.4M. TYL currently screens at market cap $25.57B and trailing P/E 89.3.
Not investment advice. Open the EBS and TYL stock pages for the full models.
Not investment advice.